Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

UFPT vs HWKN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

UFPT Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

UFPT Overall Winner 6-Pillar Tally: UFPT 4 – 2 HWKN Matrix Metrics: UFPT 6 – 4 HWKN

As of Nov 16, 2026, UFP Technologies Inc (UFPT) is the stronger overall head-to-head candidate over Hawkins Inc (HWKN) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). UFPT carries a Unified Composite Score of 42.6/100 (HOLD) at $298.54 (24.7x Forward P/E, 15.4% operating margin), whereas HWKN carries 45.0/100 (HOLD) at $148.66 (35.6x Forward P/E, 10.6% operating margin).

  • Composite vs. Pillar Nuance: While HWKN currently prints a higher short-term Unified Composite Score (45.0/100 HOLD vs. UFPT 42.6/100 HOLD), UFPT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (15.4% vs. 10.6% operating margin) and revenue trajectory (+11.6% vs. +11.9% YoY).
  • Technical & Structure Timing Caution: UFPT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8); meanwhile HWKN trades in a Markup technical trend (SURGE options phase, RSI 56.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About UFPT vs HWKN
UFPT NASDAQ Head-to-Head Winner
UFP Technologies Inc
Surgical & Medical Instruments & Apparatus
$298.54
-2.14% 1D
Market Cap $2.4B
TTM Revenue $650M
Forward P/E 24.7x
Beta / 30D Vol 1.64β · 77% Vol
Unified Composite Score
42.6 / 100 HOLD
Tech 25.0 Fund 37.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.1%) with fading momentum, RSI 50
RSI-14: 49.8 · SMA20: $298.97 · SMA50: $293.17
HWKN NASDAQ
Hawkins Inc
Wholesale-Chemicals & Allied Products
$148.66
-0.01% 1D
Market Cap $3.1B
TTM Revenue $1.14B
Forward P/E 35.6x
Beta / 30D Vol 0.54β · 52% Vol
Unified Composite Score
45.0 / 100 HOLD
Tech 28.0 Fund 42.0 Flow 52.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.2% over 20 days), RSI 57
RSI-14: 56.6 · SMA20: $147.37 · SMA50: $135.32

6-Pillar Scorecard Institutional Category Breakdown (UFPT 4 – 2 HWKN)

Columns: Metric · UFPT · HWKN
1. Valuation Multiples UFPT
Forward P/E 24.7x 35.6x
Trailing P/E 31.2x 36.1x
PEG Ratio 3.80x 2.55x
EV / Revenue 3.6x 2.9x
2. Growth & Scale HWKN
Revenue Growth (YoY) +11.6% +11.9%
Earnings Growth (YoY) +25.1% +24.1%
TTM Revenue (USD) $650M $1.14B
Market Cap $2.4B $3.1B
3. Profitability & Quality UFPT
Gross Margin 28.9% 22.4%
Operating Margin 15.4% 10.6%
Net Profit Margin 11.8% 7.5%
Return on Equity (ROE) 17.2% 16.0%
4. Balance Sheet & Cash Flow UFPT
Cash Generation (TTM) $120M EBITDA $93M
Cash Flow Margin 18.5% EBITDA Mgn 8.1%
Net Cash / Leverage $62.70 Book/Sh · 17.2% ROE $240M Net Debt (0.44x D/E)
Dividend Yield None (0.00%) 0.51%
5. Options & Positioning HWKN
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile 42.3% (3rd %ile) 26.7% (9th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution DISTRIBUTION · Markup
6. R&D & Supply-Chain Moat UFPT
OpEx & R&D Intensity 13.5% of Rev ($88M) 11.8% of Rev ($134M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: UFPT (6) vs HWKN (4)
Institutional Metric UFPT HWKN Criterion Row Edge
Market Capitalization
Scale
$2.4B $3.1B Larger Scale HWKN
Trailing P/E Ratio
Valuation
31.2x 36.1x Lower Multiple UFPT
Forward P/E Ratio
Valuation
24.7x 35.6x Lower Multiple UFPT
Revenue Growth (YoY)
Growth
+11.6% +11.9% Higher Growth HWKN
Operating Margin (TTM)
Profitability
15.4% 10.6% Higher Margin UFPT
Net Profit Margin
Profitability
11.8% 7.5% Higher Margin UFPT
Return on Equity (ROE)
Capital Efficiency
17.2% 16.0% Higher ROE UFPT
52-Week Range Position
Momentum
74% ($174–$342) 56% ($116–$174) Stronger Trend UFPT
Beta / 30D Volatility
Risk Regime
1.64β · 77% Vol 0.54β · 52% Vol Lower Realized Risk HWKN
Unified Institutional Score
Composite Signal
42.6 / 100 (HOLD) 45.0 / 100 (HOLD) Higher Composite HWKN
Trailing 12M Revenue (USD)
Operating Scale
$650M $1.14B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
28.9% 22.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.80x PEG · 3.6x EV/Rev 2.55x PEG · 2.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$120M EBITDA ($62.70 Book/Sh · 17.2% ROE) $93M ($240M Net Debt (0.44x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HWKN +10.55 pp
UFPT: +2.36% · HWKN: +12.91%
3M Horizon HWKN +24.04 pp
UFPT: -4.92% · HWKN: +19.12%
6M Horizon UFPT +41.94 pp
UFPT: +37.44% · HWKN: -4.5%
1Y Horizon UFPT +11.05 pp
UFPT: +27.42% · HWKN: +16.37%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UFPT vs HWKN. Trailing 12-month operating profitability (UFPT 15.4% vs HWKN 10.6%) and valuation multiples (UFPT 24.7x vs HWKN 35.6x Forward P/E) are benchmarked directly in Pillar 4 below.

UFPT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$650M
Gross Margin28.9%
Op. Margin15.4%
ROE / Fwd P/E17.2% · 24.7x
HWKN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.14B
Gross Margin22.4%
Op. Margin10.6%
ROE / Fwd P/E16.0% · 35.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
UFPT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 42.3%
IV Percentile 3rd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact UFPT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HWKN SURGE
8d in phase · OBV DISTRIBUTION
Current IV 26.7%
IV Percentile 9th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact HWKN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
UFPT Moat Profile Scale & Operating Efficiency Moat
Medical Devices Operator
Competes within the Medical Devices value chain with $2.4B market capitalization and 15.4% operating margin.
OpEx & R&D Reinvestment 13.5% of Rev ($88M)
90D Engineering Disclosures 0 Published
HWKN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $3.1B market capitalization and 10.6% operating margin.
OpEx & R&D Reinvestment 11.8% of Rev ($134M)
90D Engineering Disclosures 0 Published

Investor FAQ UFPT vs HWKN Key Questions & Quantitative Answers

As of Nov 16, 2026, UFP Technologies Inc (UFPT) is the stronger overall head-to-head candidate over Hawkins Inc (HWKN) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). UFPT carries a Unified Composite Score of 42.6/100 (HOLD) at $298.54 (24.7x Forward P/E, 15.4% operating margin), whereas HWKN carries 45.0/100 (HOLD) at $148.66 (35.6x Forward P/E, 10.6% operating margin). Composite vs. Pillar Nuance: While HWKN currently prints a higher short-term Unified Composite Score (45.0/100 HOLD vs. UFPT 42.6/100 HOLD), UFPT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (15.4% vs. 10.6% operating margin) and revenue trajectory (+11.6% vs. +11.9% YoY). Technical & Structure Timing Caution: UFPT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.8); meanwhile HWKN trades in a Markup technical trend (SURGE options phase, RSI 56.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HWKN leads the Growth & Scale pillar: UFPT posts +11.6% YoY revenue growth and +25.1% YoY earnings growth on $650M TTM revenue (28.9% gross margin, 15.4% operating margin), compared with HWKN at +11.9% YoY revenue growth and +24.1% YoY earnings growth on $1.14B TTM revenue (22.4% gross margin, 10.6% operating margin). On trailing 12-month operating scale, UFPT generates $650M in USD-normalized revenue versus $1.14B for HWKN. In operating R&D and SG&A reinvestment, UFPT deploys 13.5% of Rev ($88M) (0 90-day corporate R&D disclosures) versus 11.8% of Rev ($134M) (0 disclosures) for HWKN.

UFPT screens cheaper on headline valuation multiples. UFPT trades at 24.7x Forward P/E, 31.2x Trailing P/E, 3.80x PEG, and 3.6x EV/Revenue (18.5% EBITDA margin), whereas HWKN trades at 35.6x Forward P/E, 36.1x Trailing P/E, 2.55x PEG, and 2.9x EV/Revenue (8.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against UFPT (17.2% ROE) versus HWKN (16.0% ROE) capital efficiency.

In options market volatility and institutional positioning, UFPT carries 42.3% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.64β · 77% Vol realized risk). By comparison, HWKN carries 26.7% implied volatility (9th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.54β · 52% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.